Notes
Notes - notes.io |
To compare the clinical outcomes of fresh embryo transfers (ETs) and frozen-thawed embryo transfers (FETs) after a freeze-all cycle in women ≥40 years old with poor ovarian response (POR).
We performed a single-center, retrospective, case-control study of patients who underwent in vitro fertilization between January 2014 and June 2019. We included a total of 192 patients aged 40 years or older from whom 3 or fewer oocytes had been retrieved and who were receiving cleavage-stage ET in this study. Of these patients, 101 and 91 patients underwent fresh ET and FET, respectively. The primary outcome was the live birth rate (LBR) after the first ET. Logistic regression analysis was used to compare the IVF outcomes and neonatal characteristics between the fresh ET and FET groups, adjusting for maternal age, body mass index, luteinizing hormone, and the number of good quality embryos transferred.
The mean maternal ages and number of oocytes retrieved (43.2 years and 2.3 in both groups, P=0.902 and P=0.927, respectively) were similar in the fresh ET and FET groups. No significant difference was observed between the LBRs of the fresh ET and FET groups (adjusted odds ratio, 1.28; 95% confidence interval, 0.29-5.70). The clinical pregnancy and miscarriage rates, and neonatal characteristics (birth weights and premature infant rates) were similar between the 2 groups.
s FET after the freeze-all strategy had no beneficial impact on the clinical outcomes of women ≥40 years with POR.
s FET after the freeze-all strategy had no beneficial impact on the clinical outcomes of women ≥40 years with POR.
To assess the impact of the COVID-19 pandemic and associated lockdowns on public interest in ophthalmology.
Search interest data for ophthalmic services and conditions were collected from January 1, 2019 to June 21, 2020. Temporal statistical analysis was used to identify significant trends. Weekly data on ophthalmic services and conditions search interest obtained from Google Trends were analyzed with analysis of variance testing and the generalized linear model based on dates.
Ophthalmic services searches decreased after the first COVID-19 case in the country (p<0.001); ophthalmic services and conditions search interest also declined after the first COVID-19 case and lockdown orders in each state (p<0.001). Following the first in-state COVID-19 case, search interest in ophthalmic services fell more than for ophthalmic conditions (p=0.0088). Lockdown and COVID-19 had similar effects on ophthalmic services search interest (p=0.2246), but interest in ophthalmic conditions decreased more after lockdown than after the first in-state case (p<0.0001).
Most of the decrease in search interest in ophthalmic services was associated with COVID-19 rather than lockdown orders, suggesting that public interest in ophthalmic care may be more sensitive to changes in the COVID-19 pandemic than lockdown orders.
Most of the decrease in search interest in ophthalmic services was associated with COVID-19 rather than lockdown orders, suggesting that public interest in ophthalmic care may be more sensitive to changes in the COVID-19 pandemic than lockdown orders.
To describe characteristics of children undergoing SARS-CoV-2 testing during the initial wave of infections in Rhode Island.
This is a descriptive study of 729 children tested for SARS-CoV-2 at four emergency departments April 9 to May 7, 2020 in Rhode Island. Demographic information and symptoms were cataloged for those tested.
81 (11%) children tested positive for SARS-CoV-2. 94% of positive children were symptomatic. 74% of positive cases had constitutional symptoms and 72% had upper respiratory symptoms. While only 34% of those tested were Hispanic, 68% of the SARS-CoV-2- positive cases occurred in Hispanic children.
This study details the pediatric population's experience during the first wave of the pandemic in Rhode Island. It could inform testing allocation strategies in healthcare settings. It also highlights vulnerable populations in need of further public health support in our state.
This study details the pediatric population's experience during the first wave of the pandemic in Rhode Island. It could inform testing allocation strategies in healthcare settings. It also highlights vulnerable populations in need of further public health support in our state.
To compare treatment retention in a Medication for Opioid Use Disorder program between older and younger adults with opioid use disorder.
This retrospective cohort study was conducted from 2015 to 2018 at an urban academic hospital's opioid and drug treatment center. Participants were adults, 18 and older, diagnosed with Opioid Type Dependence. Older adults were defined as age 50 and older. Poisson and logistic regression analyses examined whether older age was associated with treatment retention.
Overall, 288 individual charts were reviewed; 123 were aged 18-49, and 78 were aged 50 and older. Older adults were more likely to stay in treatment for six months or longer (OR=1.73, [1.02, 2.96], P-value = 0.04] and have a higher number of treatment visits overall (RR=1.06, [0.98, 1.16] (P-value=0.16).
Older adults are more likely than younger adults to be retained in long-term treatment in a Medication for Opioid Use Disorder program.
Older adults are more likely than younger adults to be retained in long-term treatment in a Medication for Opioid Use Disorder program.
Suboptimal adherence to medication and lifestyle modification continues to be a problem in diabetic patients in the US. Previous studies have investigated the potential of group educational visits in improving medication adherence and short-term health outcomes, but few have done so using a biopsychosocial approach in visits. This study aimed to evaluate the effect that group visits, conducted using an integrated behavioral health model at a primary care practice, had on A1c and distress levels in diabetic adults.
Using the Diabetic Distress Scale (DDS), 15 adults were identified as having moderate diabetic distress (> 3.0) between December 2016 and May 2017 and invited to attend a group visit in May 2017 to address identified barriers. Of those, nine attended. The group visit, conducted by a psychologist, sought to reduce diabetic distress by targeting behavioral and social factors, including improving social and familial support, using diabetes online forums, and improving mind-body connection. HDAC inhibitor Repeat A1c and DDS measurements for all nine visit participants were collected three months after.
Here's my website: https://www.selleckchem.com/products/wnt-agonist-1.html
|
Notes.io is a web-based application for taking notes. You can take your notes and share with others people. If you like taking long notes, notes.io is designed for you. To date, over 8,000,000,000 notes created and continuing...
With notes.io;
- * You can take a note from anywhere and any device with internet connection.
- * You can share the notes in social platforms (YouTube, Facebook, Twitter, instagram etc.).
- * You can quickly share your contents without website, blog and e-mail.
- * You don't need to create any Account to share a note. As you wish you can use quick, easy and best shortened notes with sms, websites, e-mail, or messaging services (WhatsApp, iMessage, Telegram, Signal).
- * Notes.io has fabulous infrastructure design for a short link and allows you to share the note as an easy and understandable link.
Fast: Notes.io is built for speed and performance. You can take a notes quickly and browse your archive.
Easy: Notes.io doesn’t require installation. Just write and share note!
Short: Notes.io’s url just 8 character. You’ll get shorten link of your note when you want to share. (Ex: notes.io/q )
Free: Notes.io works for 12 years and has been free since the day it was started.
You immediately create your first note and start sharing with the ones you wish. If you want to contact us, you can use the following communication channels;
Email: [email protected]
Twitter: http://twitter.com/notesio
Instagram: http://instagram.com/notes.io
Facebook: http://facebook.com/notesio
Regards;
Notes.io Team